Intraperitoneal administration of thermosensitive hydrogel Co-loaded with norcantharidin nanoparticles and oxaliplatin inhibits malignant ascites of hepatocellular carcinoma

• Main Authors: Susu Xiao (Author), Yu Wang (Author), Wenqiong Ma (Author), Ping Zhou (Author), Biqiong Wang (Author), Zhouxue Wu (Author), Qian Wen (Author), Kang Xiong (Author), Yanlin Liu (Author), Shaozhi Fu (Author)
• Format: Book
• Published: Taylor & Francis Group, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Malignant ascites is a common complication of some advanced cancers. Although intraperitoneal (IP) administration of chemotherapy drugs is routinely used to treat cancerous ascites, conventional drugs have poor retention and therefore need to be administered frequently to maintain a sustained anti-t...